• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM Back to Search Results
Catalog Number 22443-19
Device Problem Failure to Advance (2524)
Patient Problems Intimal Dissection (1333); Vasoconstriction (2126)
Event Date 12/14/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all relevant information.
 
Event Description
It was reported that resistance was met during advancement of the nav 6 embolic protection device (epd) through the mildly calcified, moderately tortuous, 80% stenosed, de novo, mid carotid artery, resulting in a dissection from the tip of the guide wire.A spasm was noted at the site of the dissection and nitroglycerin was administered.The device was removed from the anatomy.A different epd was placed and an abbott stent was implanted to cover the dissection and complete the procedure.There was no reported adverse patient sequela or a clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
(b)(4).Evaluation summary: visual inspection was performed on the returned device.The reported difficulty advancing was not able to be confirmed as it was based on case circumstances.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no similar incidents.Dissection and vasospasm are listed in the emboshield nav 6 instruction for use (ifu) as adverse events potentially associated with carotid stents and embolic protection systems.The failure to advance and subsequent patient effects were likely due to anatomical conditions and there is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM
Type of Device
EMBOLIC PROTECTION SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6226965
MDR Text Key63991225
Report Number2024168-2017-00119
Device Sequence Number1
Product Code NTE
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K090665
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 03/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2019
Device Catalogue Number22443-19
Device Lot Number6072061
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/07/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/27/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-